A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients.

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) ...

Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the ...

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

Aspirin has been shown to effectively reduce recurrence rates and improve disease-free survival,” said Anna Martling, MD, PhD.

Safety: Aspirin was well-tolerated, with no major safety concerns reported. The ASCOLT trial showed that aspirin did not ...

Seohyuk Lee et al, Adjuvant aspirin therapy and colorectal cancer survival, The Lancet Gastroenterology & Hepatology (2025). DOI: 10.1016/S2468-1253(24)00393-5 Journal information: The Lancet ...

Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...

Aspirin reduced disease recurrence in patients PI3K-mutated colorectal cancer, underscoring the value of early genomic ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.